Market closedNon-fractional
Enfusion/ENFN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.
Ticker
ENFN
Sector
Technology
Trading on
NYSE
Industry
Software
Headquarters
Chicago, United States
Employees
1,102
Website
www.enfusion.com
Enfusion Metrics
BasicAdvanced
$870M
Market cap
374.41
P/E ratio
$0.03
EPS
0.97
Beta
-
Dividend rate
Price and volume
Market cap
$870M
Beta
0.97
Financial strength
Current ratio
4.075
Quick ratio
3.667
Long term debt to equity
13.229
Total debt to equity
18.711
Management effectiveness
Return on assets (TTM)
3.31%
Return on equity (TTM)
4.18%
Valuation
Price to earnings (TTM)
374.412
Price to revenue (TTM)
4.608
Price to book
14.65
Price to tangible book (TTM)
14.65
Price to free cash flow (TTM)
51.106
Growth
Revenue change (TTM)
15.55%
Earnings per share change (TTM)
-13.74%
3-year revenue growth (CAGR)
28.62%
What the Analysts think about Enfusion
Analyst Ratings
Majority rating from 8 analysts.
Enfusion Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$48M
3.45%
Net income
-$500K
-183.33%
Profit margin
-1.04%
-180.62%
Enfusion Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.04
$0.04
$0.06
-
Expected
$0.04
$0.05
$0.05
$0.04
$0.06
Surprise
-4.11%
-12.50%
-23.81%
65.52%
-
Enfusion News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enfusion stock?
Enfusion (ENFN) has a market cap of $870M as of July 27, 2024.
What is the P/E ratio for Enfusion stock?
The price to earnings (P/E) ratio for Enfusion (ENFN) stock is 374.41 as of July 27, 2024.
Does Enfusion stock pay dividends?
No, Enfusion (ENFN) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Enfusion dividend payment date?
Enfusion (ENFN) stock does not pay dividends to its shareholders.
What is the beta indicator for Enfusion?
Enfusion (ENFN) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Enfusion stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.